Next Article in Journal
Generation of Myeloid-Derived Suppressor Cells Mediated by MicroRNA-125a-5p in Melanoma
Next Article in Special Issue
Carotenoid Supplementation for Alleviating the Symptoms of Alzheimer’s Disease
Previous Article in Journal
Ocular Changes in Cystic Fibrosis: A Review
Previous Article in Special Issue
Preparation of Esterified Starches with Different Amylose Content and Their Blending with Polybutylene Succinate
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Talaroacids A–D and Talaromarane A, Diterpenoids with Anti-Inflammatory Activities from Mangrove Endophytic Fungus Talaromyces sp. JNQQJ-4

1
School of Chemistry, Sun Yat-sen University, Guangzhou 510275, China
2
School of Pharmacy, Anhui Medical University, Hefei 230032, China
*
Authors to whom correspondence should be addressed.
Int. J. Mol. Sci. 2024, 25(12), 6691; https://doi.org/10.3390/ijms25126691
Submission received: 24 May 2024 / Revised: 11 June 2024 / Accepted: 14 June 2024 / Published: 18 June 2024
(This article belongs to the Special Issue Nutrients and Active Substances in Natural Products)

Abstract

:
Five new diterpenes including four diterpenes with 1,2,3,4,4a,5,6,8a-octalin skeleton talaroacids A–D (14) and an isopimarane diterpenoid talaromarane A (5) were isolated from the mangrove endophytic fungus Talaromyces sp. JNQQJ-4. Their structures and absolute configurations were determined by analysis of high-resolution electrospray ionization mass spectroscopy (HRESIMS), 1D/2D Nuclear Magnetic Resonance (NMR) spectra, single-crystal X-ray diffraction, quantum chemical calculation, and electronic circular dichroism (ECD). Talaromarane A (5) contains a rare 2-oxabicyclo [3.2.1] octan moiety in isopimarane diterpenoids. In bioassays, compounds 1, 2, 4, and 5 displayed significant anti-inflammatory activities with the IC50 value from 4.59 to 21.60 μM.

Graphical Abstract

1. Introduction

Diterpenoids are a class of terpenoids containing 20 carbons and consist of four isopentenyl groups, which are widely distributed in animals, plants, and microorganisms [1]. More than 100 basic diterpene skeletons have been found, which can be divided into linear, monocarbocyclic, bicarbocyclic, tricarbocyclic, tetracarbocyclic, and pentacarbocyclic [2]. Among diverse skeleton types of diterpenes, diterpenes with decalin skeleton mainly include labdane [3], clerodane [4], and other types of diterpenes [5]. These diterpenes have a variety of pharmacological activities including anticancer [6,7], anti-inflammatory [8,9,10], antiparasitical [11], antiviral [12], enzyme inhibition [13,14], immunosuppressive [15], anti-angiogenesis [16], and antidiabetic [17].
Mangrove ecosystems are usually located at the junction of land and ocean in tropical and subtropical regions and have abundant plant resources [18]. These mangrove plants, such as Kandelia obovata, were often used as traditional folk medicines [19]. In addition, due to the extreme environment of high salt, high temperature, local hypoxia, and periodic seawater immersion in mangroves, there are a variety of endophytic fungi resources [20]. Mangrove endophytic fungi can produce secondary metabolites with unique structures and remarkable biological activities, which capture the attention of numerous natural products and pharmacology researchers [21,22,23,24,25,26,27,28]. To date, more than 1300 new compounds have been identified from mangrove-derived fungi [29]. In our ongoing research search for bioactive compounds from mangrove endophytic fungi [30,31,32,33], the strain Talaromyces sp. JNQQJ-4 isolated from the leaf of Kandelia obovata was investigated. Four new diterpenes with 1,2,3,4,4a,5,6,8a-octalin skeleton talaroacids A–D (14) and a new isopimarane diterpenoid talaromarane A (5) were isolated from Talaromyces sp. JNQQJ-4 (Figure 1). In bioassay, compounds 1, 2, 4, and 5 indicated significant anti-inflammatory activities with IC50 values from 4.59 to 21.60 µM. Herein, the isolation, structure elucidation, and biological assays of isolated diterpenoids are described.

2. Results and Discussion

2.1. Structure Identification

Talaroacid A (1) was obtained as a white powder, and had a molecular formula of C20H32O3 with five degrees of unsaturation based on the HRESIMS (Figure S1) data. The 1H NMR spectrum (Table 1 and Figure S2) indicated four methyl groups at δH 1.62 (s, H3-17), 0.95 (s, H3-20), 0.89 (s, H3-19), and 0.83 (s, H3-18); an olefinic proton signal at δH 5.49 (m, H-15). The 13C NMR (Table 2 and Figure S3) and HSQC spectra (Figure S4) data of 1 exhibited 20 carbon signals, including a carbonyl carbon, four methyls, four olefinic carbons (three non-hydrogenated carbons), eight methylenes (an oxygenated), a methine, and two quaternary carbons.
The key HMBC correlations (Figure 2 and Figure S6) from H2-7 to C-8 and C-9; from H3-18/H3-19 to C-3, C-4, and C-5; from H3-20 to C-1, C-5, C-9, and C-10 together with the spin system of H2-1/H2-2/H2-3 and H-5/H2-6/H2-7 indicated the presence of a 5,5,9-trimethyl-Δ1,2-octalin moiety of 1. The HMBC correlations from H2-11 to C-8, C-9, C-10, and C-11 (δC 178.0) revealed the branched chain of acetic acid located at C-9. Furthermore, the spin coupling system (Figure S5) of H-15/H2-16 and the HMBC correlations from H3-17 to C-13, C-14, and C-15; from H2-16 to C-13; from H2-13 to C-7, C-8, and C-9 indicated the fragment of 3-methylbut-2-en-1-ol was linked to C-8. Thus, the planar structure of 1 was established and shown. The NOESY correlations (Figure 3 and Figure S7) between H-15 and H3-17 ensure the configuration of the Δ14 double bond as 14Z. Furthermore, the NOESY correlations of H3-18/H3-20 revealed they were positioned on the same face. In turn, the correlation of H-5/H3-19 suggested they were at the opposite orientation. Based on the above information, the relative configuration of 1 was assigned to 5S* and 10S*. Finally, the absolute configuration of 1 was determined as 5S, 10S, and 14Z based on a comparison of experimental and calculated ECD spectra (Figure 4).
Talaroacid B (2) was obtained as a white powder. The HRESIMS data (Figure S8) suggested that 2 had the same molecular formula as that of 1. The NMR data (Table 1 and Table 2; Figures S9–S11) closely resembled those of 1, except for the chemical shift at C-15 (Δδc −2.4). The 1H-1H COSY spectra and (Figure S12) and HMBC spectra (Figure S13) also indicate that compounds 2 and 1 have similar planar structures. The NOESY correlation (Figure 3 and Figure S14) of H-15/H2-13 indicated that the configuration of Δ14 double bond of 2 was 14E. Furthermore, the absolute configuration of 2 was determined as 5S, 10S, and 14E according to the NOESY correlations and ECD calculation (Figure 4).
Talaroacid C (3) was obtained as a white powder and shared the same molecular formula as that of 2 based on the HRESIMS data (Figure S15). Comparing the NMR data (Table 1 and Table 2; Figures S16–S18) of compounds 3 and 2 showed that 3 had a similar structure to 2. While, the 1H-1H COSY spectrum (Figure S19) and the HMBC correlations (Figure 2 and Figure S20) from H2-15 to C-13 (δC 129.2), C-14 (δC 135.1), and C-17 (δC 17.2); from H-13 (δH 5.65) to C-7 (δC 32.6), C-8 (δC 134.1), and C-9 (δC 137.6) revealed that the Δ14 double bond in 2 has changed to Δ13 double bond in 3. Then, the configuration of Δ13 double bond of 3 was assigned as 13E based on the NOESY correlation of H-13/H2-15 (Figure 3 and Figure S21). Finally, the analysis of NOESY correlations and ECD calculation (Figure 4) determined the absolute configuration of 3 as 5S, 10S, and 13E.
Talaroacid D (4), a white powder, had a molecular formula of C20H34O3 and 4 degrees of unsaturation according to the HRESIMS data (Figure S22). The structure of 4 was similar to 2 by comparison of their NMR data (Table 1 and Table 2; Figures S23–S25). The main difference was the Δ14 double bond in 2 was reduced in 4. The deduction was further confirmed by the 1H-1H correlations (Figure 2 and Figure S26) of H2-13/H-14(H3-17)/H2-15/H2-16 and the HMBC correlations (Figure 2 and Figure S27) from H3-17 to C-13 (δC 41.2), C-14 (δC 28.4), and C-15 (δC 40.1). Thus, the planar structure of 4 was established. According to the similar NOESY correlations (Figure 3 and Figure S28), the relative configuration of 4 was assigned to 5S* 10S*. Furthermore, to determine the relative configuration of C-14 in the side chain, the 13C NMR calculations of two possible structures (5S*,10S*,14S*)-4 and (5S*,10S*,14R*)-4 were performed using the gauge-including atomic orbital (GIAO) method at mPW1PW91-SCRF/6-311+G (d,p)/PCM (Chloroform). The results indicated that (5S*,10S*,14S*)-4 was a reasonable structure (Figure 5, Figures S36 and S37) with a better correlation coefficient (R2 = 0.9985) and a high DP4+ probability score at 100% (all data). Finally, the absolute configuration of 4 was determined as 5S, 10S, and 14S based on the same experimental and calculated ECD spectra (Figure 4).
Talaromarane A (5) was obtained as a colorless crystal with the molecular formula of C22H30O8 and 8 degrees of unsaturation according to the HRESIMS data (Figure S29). The 1H NMR spectrum (Table 1 and Figure S30) revealed two hydroxyl proton signals at δH 4.94 (s, OH-5), and 3.90 (s, OH-7); four methyls at δH 2.13 (s, H3-22), 1.30 (s, H3-18), 1.27 (s, H3-19), and 1.00 (s, H3-17); four olefinic proton signals at δH 5.88 (s, H-14), 5.82 (dd, J = 17.5, 10.6 Hz, H-15), 5.04 (dd, J = 17.5, 1.0 Hz, H-16a), and 4.99 (dd, J = 10.6, 1.0 Hz, H-16b). Analysis 13C NMR (Table 2 and Figure S31) and HSQC data (Figure S32) to obtain 22 carbons including four methyls, five methylenes (one olefinic), four methines (two olefinic and an oxygenated), six non-hydrogenated carbons (two carbonyl carbons, three oxygenated and an olefinic), and three quaternary carbons. These data suggested that 5 belongs to an isopimarane diterpene [30]. The 1H-1H COSY correlations (Figure 2 and Figure S33) of H2-1/H2-2/H-3, H2-11/H2-12, and H-15/H2-16 together with the HMBC correlations from H-1 to C-10 and C-20; H3-18/19 to C-3, C-4 and C-5; H-7 to C-5, C-6, C-8, C-9, and C-14; H3-17 to C-12, C-13, and C-14; H-15 to C-14 and from H-11 to C-9 and C-10 to establish a typical tricyclic isopimarane diterpene skeleton. The acetyl group was located at C-3 based on the HMBC correlations (Figure 2 and Figure S34) from H3-22 (δH 2.13) and H-3 (δH 4.70) to C-21 (δC 168.9). The deshielding chemical shift at C-7 (δH/δC 4.74/70.9) indicates that a hydroxyl group was located at C-7 in 5. Moreover, the HMBC correlations from H-7 (δH 4.74) to non-hydrogenated carbons C-5 (δC 83.3), C-6 (δC 105.0), and C-9 (δC 73.2) revealed they were replaced by hydroxy groups, respectively. The HMBC correlations from H-1 to C-20 (δC 172.7) and the remaining unsaturation together with the deshielding chemical shift at non-hydrogenated carbon C-6 (δC 105.0) indicate that an oxygen bridge between C-7 and C-20. Thus, the plate structure of 5 was established.
The NOESY correlations (Figure S35) of H-3/H-6/H-15/H3-18 indicated that these protons were in the same orientation. However, due to the absence of key NOE correlations for OH-5, OH-6, and OH-9 in the NOE spectrum (CDCl3), the relative configurations of 5 were difficult to determine. Luckily, the single crystal of 5 was successfully obtained by slow volatilization in MeOH. Finally, the absolute configuration of 5 was unambiguously determined as 3R, 5R, 6R, 7R, 9R, 10S, and 13R using single crystal X-ray diffraction analysis with a flack parameter of −0.22 (8) (Figure 6). In addition, ECD calculation also verifies the conclusion above (Figure 4).

2.2. Anti-Inflammatory Activities

On RAW264.7 cells test all compound’s cytotoxicity and anti-inflammatory activities (Table 3). The results indicated compound 2 had better anti-inflammatory activities than positive control quercetin (IC50 = 11.33 μM) with IC50 values of 4.59 μM. Compounds 1, 4, and 5 showed moderate anti-inflammatory activities with IC50 values of 15.78, 21.60, and 13.38 μM, respectively. None of the compounds were cytotoxic to RAW264.7 cells at the tested concentrations.

3. Materials and Methods

3.1. General Experiment Procedures

The optical rotations were recorded by using an MCP300 (Anton Paar, Shanghai, China). UV spectrum was obtained using a Shimadzu UV-2600 spectrophotometer (Shimadzu, Kyoto, Japan). The CD spectra were obtained from a J-810 spectropolarimeter in MeOH (JASCO, Tokyo, Japan). The IR data were performed on a Shimadzu IRTrace-100 spectrometer (Shimadzu, Tokyo, Japan) in KBr discs. All NMR data were measured on a Bruker Advance 600 MHz spectrometer at room temperature using the signals of residual solvent protons (CDCl3: δH/δC 7.26/77.1; CD3OD: δH/δC 3.31/49.2). The HRESIMS data were recorded by using a ThermoFisher LTQ-Orbitrap-LC-MS spectrometer (Palo Alto, CA, USA). Semi-preparative HPLC (Ultimate 3000 BioRS, Thermo Scientific, Waltham, MA, USA) was conducted using a semipreparative column (5 μm, 10 × 250 mm, Ultimate XB-C18, Welch Materials, Inc., Shanghai, China). A Rigaku XtaLAB Pro diffractometer (Rigaku, Tokyo, Japan) was used to obtain the crystallographic data of 5 (Cu Kα radiation). Column chromatography (CC) was performed using silica gel (200–300 mesh, Qingdao Marine Chemical, Qingdao, China) and Sephadex LH-20 (Sigma-aldrich, Saint Louis, MO, USA).

3.2. ECD and NMR Calculations

The ECD calculation was carried out using described previously [30]. The conformers were subjected to geometric optimization at the level of B3LYP/6-31+G (d,p) and the optimized conformers were calculated on the TD-DFT method using the B3LYP/6-311+G (d,p). All NMR calculations were performed using the GIAO method at mPW1PW91-SCRF/6-311+G (d,p)/PCM (Chloroform) [34].

3.3. Plant and Fungal Material

The healthy leaves of Kandelia obovata were collected in Jinniu Island Mangrove Nature Reserve in Guangzhou province of China in July 2023. The plant was identified by Dr. Yayue Liu, Guangdong Ocean University, and voucher sp. (JNQJ202306) is stored at Sun Yat-sen University. The strain Talaromyces sp. JNQQJ-4 was isolated from the healthy leaves of Kandelia obovate. The specific separation process was as follows: the fresh leaf tissue of Kandelia candel was transferred to 3% sodium hypochlorite solution and 75% ethanol solution with sterilized tweezers, and washed with sterile water. The leaf tissue was cut into regular small pieces (about 0.2 × 0.6 cm) and cultured on an autoclaved Bengal Rose agar plate incubated at 28 °C for 3 days. After the colony appeared, the mycelia were picked and inoculated on PDA medium. Repeat the above steps until a pure single colony is obtained on PDA plate. Fungal species were identified using DNA amplification and ITS sequence analysis previously [35]. The strain sequence data were reserved for the GenBank with accession number PP660349, and BLAST analysis revealed that it was 100% homologous to the sequence of Talaromyces sp. (MK450749.1). This strain was preserved at Sun Yat-sen University, China.

3.4. Fermentation, Extraction and Purification

The fungal strain was seeded to sixty 1 L Erlenmeyer flasks with 70 g raw rice and 30 mL 0.3% seawater and incubated at 25 °C for 28 days. The solid rice media were extracted with ethyl acetate and concentrated to obtain 45.9 g of crude extract. Five fractions (Fr.A-Fr.E) were isolated from the extract using silica gel CC (200–300 mesh) eluting with petroleum ether/ethyl acetate gradient (1:0~0:1). Fractions B was purified using CC on silica gel (CH2Cl2/MeOH, 80:1) and Sephadex LH-20 (CH2Cl2/MeOH, 1:1) to produce subfractions B1–B3. Fr. B2 was purified using semipreparative HPLC (CH3CN/H2O/Trifluoroacetic acid, 60:40:0.05, 1.5 mL/min) to obtain compounds 1 (5.3 mg, tR = 13.5 min), 2 (4.8 mg, tR = 14.5 min), 3 (4.5 mg, tR = 17.0 min), and 4 (3.6 mg, tR = 19.0 min). Fr. C1–C4 was obtained by separating fractions C using CC on a silica gel (CH2Cl2/MeOH, 75:1). Then, compound 5 (3.3 mg, tR = 14.2 min) was obtained using semipreparative HPLC (CH3CN /H2O, 70:30, 1.5 mL/min) from Fr. C1.
Talaroacid A (1): white powder.; [ α ] D 25 = 10.4 (c 0.23, MeOH); UV (MeOH) λmax (log ε): 201 (2.26) nm; ECD (c 0.33 mM, MeOH) λmaxε) 201 (30.5), 218 (20.3) nm; IR (KBr) νmax: 3326, 2935, 1706, 1445, 1385 and 1180 cm−1; 1H NMR (500 MHz, MeOH-d4) data, Table 1; 13C NMR (125 MHz, MeOH-d4) data, Table 2; HRESIMS m/z 343.2246 [M + Na]+ (calcd: C20H32O3Na, 343.2244).
Talaroacid B (2): white powder.; [ α ] D 25 = 8.8 (c 0.25, MeOH); UV (MeOH) λmax (log ε): 201 (1.56) nm; ECD (c 0.33 mM, MeOH) λmaxε) 203 (27.5) nm; IR (KBr) νmax: 3328, 2940, 1712, 1447, 1390 and 1175 cm−1; 1H NMR (500 MHz, CDCl3) data, Table 1; 13C NMR (125 MHz, CDCl3) data, Table 2; HRESIMS m/z 343.2238 [M + Na]+ (calcd: C20H32O3Na, 343.2244).
Talaroacid C (3): white powder.; [ α ] D 25 = 12.3 (c 0.28, MeOH); UV (MeOH) λmax (log ε): 201 (1.88) nm; ECD (c 0.33 mM, MeOH) λmaxε) 208 (19.5), 225 (25.3) nm; IR (KBr) νmax: 3327, 2938, 1716, 1450, 1388 and 1171 cm−1; 1H NMR (500 MHz, CDCl3) data, Table 1; 13C NMR (125 MHz, MeOH-d4) data, Table 2; HRESIMS m/z 343.2246 [M + Na]+ (calcd: C20H32O3Na, 343.2244).
Talaroacid D (4): white powder.; [ α ] D 25 = 5.3 (c 0.28, MeOH); UV (MeOH) λmax (log ε): 201 (1.23) nm; ECD (c 0.33 mM, MeOH) λmaxε) 201 (1.5), 225 (1.8) nm; IR (KBr) νmax: 3325, 2936, 1714, 1448, 1389 and 1173 cm−1; 1H NMR (500 MHz, CDCl3) data, Table 1; 13C NMR (125 MHz, CDCl3) data, Table 2; HRESIMS m/z 345.2401 [M + Na]+ (calcd: C20H34O3Na, 345.2400).
Talaromarane A (5): colorless crystal; [ α ] D 25 = 8.3 (c 0.30, MeOH); UV (MeOH) λmax (log ε): 201 (1.80) nm; ECD (c 0.35 mM, MeOH) λmaxε) 210 (8.0); IR (KBr) νmax: 3422, 2928, 1637 cm−1; 1H NMR (500 MHz, CDCl3) data, Table 1; 13C NMR (125 MHz, CDCl3) data, Table 2; HRESIMS m/z 421.1869 [M − H] (calcd: C22H29O7, 421.1868).

3.5. Crystallographic Data for Talaromarane A

The X-ray diffraction data of talaromarane A (5) were measured using a Rigaku XtaLAB Pro diffractometer with CuKα radiation (λ = 1.54184 Å). The structure of 5 was resolved using SHELXT methods and refined by full-matrix least-squares difference Fourier techniques on an OLEX2 interface program. The crystallographic data of 5 were preserved at the Cambridge Crystallographic Data Centre.
Molecular formula C22H30O8, formula weight 422.46, orthorhombic, space group = P212121, unit cell: a = 8.71630 (10) Å α = 90°, b = 11.06960(10) Å β = 90°, c = 21.1646(2) Å γ = 90°, V = 2042.09(4) Å3, ρcalcg = 1.374 cm3, Z = 4, T = 99.98(10) K, μ (CuKα) = 0.868 mm−1, F (000) = 904.0. A total of 16096 reflections (8.356° ≤ 2Θ ≤ 148.688°) were measured with 4108 independent reflections (Rint = 0.0453, Rsigma = 0.0337). Final R indexes [I ≥ 2σ (I)]: R1 = 0.0320, wR2 = 0.0841. Final R indexes [all data]: R1 = 0.0336, wR2 = 0.0841. Largest diff. peak and hole = 0.24 and −0.18 eÅ−3. Flack parameter = −0.22 (8). Crystallographic data for the structure reported in this paper were deposited in the Cambridge Crystallographic Data Centre (Accession No. CCDC 2351536).

3.6. Anti-Inflammatory Assay

Standard Anti-inflammatory assays employing RAW264.7 cell lines were carried out as described previously [30]. All compounds were tested for cytotoxic activity before anti-inflammatory testing. The RAW264.7 cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM, Gibco, NY, USA) at 37 °C with 5% CO2 humidified incubator. Quercetin (Sigma, Burlington, VT, USA) or compound was dissolved in DMSO to prepare mother liquor (10 mm/mL). Cytotoxic activity was tested by MTT assay. The cells were pretreated with different concentrations of quercetin or compounds (5, 10, 20, 30, 40, and 50 µM) for 24 h, then 10 µL of MTT (0.5 mg/mL) was added to each well and cultured for 4 h to test the absorbance at 540 nm. The concentration of DMSO was 0.2% of the medium culture. The NO content was determined by the Griess method to evaluate the anti-inflammatory activity of the compounds. Firstly, 500 μL cells (3 × 106 cells/mL) were seeded in 24-well plates and cultured overnight. Different concentrations of quercetin or compounds (5, 10, 20, 30, 40, and 50 µM) pretreated with LPS were added and cultured for 24 h, and the absorbance of final products was measured at 540 nm. None compounds displayed cytotoxic on RAW264.7 cell at 50 µM. Quercetin was the positive control.

3.7. Solubility and the Stability

Compounds 15 were dissolved in chloroform, and no change in compounds 15 was found by TLC detection after overnight storage. It was shown that compounds 15 were stable under normal conditions.

4. Conclusions

In conclusion, four new diterpenes with 1,2,3,4,4a,5,6,8a-octalin skeleton talaroacids A-D (14) and a new isopimarane diterpenoid talaromarane A (5) were isolated from the mangrove endophytic fungus Talaromyces sp. JNQQJ-4. It is noteworthy that 5 contains a rare 2-oxabicyclo [3.2.1] octan moiety in isopimarane. Moreover, compound 2 exhibited promising NO inhibitory activity with IC50 values of 4.59 μM. In addition, the better activity of compounds 12 than 34 indicated that the Δ14 double bond in the side chain makes a contribution to NO inhibitory activity. Nitric oxide (NO) is a signaling molecule produced by inducible nitric oxide synthase (iNOS), playing an important regulatory role in the occurrence and development of inflammation [36]. It is closely related to many major inflammation-induced diseases, such as autoimmune diseases, arthritis, cardiovascular diseases, and diabetes [37]. Inhibiting the production of NO can reduce inflammatory responses and prevent subsequent diseases [38]. Therefore, NO inhibitors were considered a promising direction for anti-inflammatory drug research [39]. Recently, several diterpenes with decalin skeleton have been reported to have significant NO inhibitory activity [40,41,42]. Among diterpenes, tinopanoid M, a clerodane diterpenoid isolated from Tinospora crispa, exerts good anti-inflammatory effects by reducing the expression of various pro-inflammatory factors and modulating multiple inflammatory pathways [41]. Thus, talaroacid B (2) might be worthy of further study as a potential anti-inflammatory lead compound.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/ijms25126691/s1.

Author Contributions

G.W. performed the separative experiments and structure identification; J.W. and Z.L. carried out the anti-inflammatory activity; T.C., Y.L. and B.W. participated in the experiments. G.W. wrote the manuscript and Z.S. and Y.C. revised it. All authors have read and agreed to the published version of the manuscript.

Funding

We thank the Guangdong Marine Economy Development Special Project (GDNRC [2023]39), the National Natural Science Foundation of China (U20A2001, 42276144), and the Natural Science Foundation of Anhui Province (2308085QH302) for generous support.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data is contained within the article and Supplementary Materials.

Acknowledgments

The authors sincerely thank the South China Sea Institute of Oceanology, and Chinese Academy of Sciences for the collection of experimental ECD spectra, UV spectra, and specific rotation data.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Hanson, J.R. Diterpenoids of Terrestrial Origin. Nat. Prod. Rep. 2015, 32, 1654–1663. [Google Scholar] [CrossRef] [PubMed]
  2. Hanson, J.R.; Nichols, T.; Mukhrish, Y.; Bagley, M.C. Diterpenoids of Terrestrial Origin. Nat. Prod. Rep. 2019, 36, 1499–1512. [Google Scholar] [CrossRef] [PubMed]
  3. Peters, R.J. Two Rings in Them All: The Labdane-Related Diterpenoids. Nat. Prod. Rep. 2010, 27, 1521. [Google Scholar] [CrossRef] [PubMed]
  4. Li, R.; Morris-Natschke, S.L.; Lee, K.-H. Clerodane Diterpenes: Sources, Structures, and Biological Activities. Nat. Prod. Rep. 2016, 33, 1166–1226. [Google Scholar] [CrossRef] [PubMed]
  5. Roncero, A.M.; Tobal, I.E.; Moro, R.F.; Díez, D.; Marcos, I.S. Halimane Diterpenoids: Sources, Structures, Nomenclature and Biological Activities. Nat. Prod. Rep. 2018, 35, 955–991. [Google Scholar] [CrossRef] [PubMed]
  6. Zhang, J.; Li, Y.; Zhu, R.; Li, L.; Wang, Y.; Zhou, J.; Qiao, Y.; Zhang, Z.; Lou, H. Scapairrins A–Q, Labdane-Type Diterpenoids from the Chinese Liverwort Scapania irrigua and Their Cytotoxic Activity. J. Nat. Prod. 2015, 78, 2087–2094. [Google Scholar] [CrossRef] [PubMed]
  7. Ma, J.; Yang, X.; Zhang, Q.; Zhang, X.; Xie, C.; Tuerhong, M.; Zhang, J.; Jin, D.-Q.; Lee, D.; Xu, J.; et al. Cytotoxic Clerodane Diterpenoids from the Leaves of Casearia kurzii. Bioorg. Chem. 2019, 85, 558–567. [Google Scholar] [CrossRef] [PubMed]
  8. Wang, C.-L.; Dai, Y.; Zhu, Q.; Peng, X.; Liu, Q.-F.; Ai, J.; Zhou, B.; Yue, J.-M. Laeviganoids A–T, Ent -Clerodane-Type Diterpenoids from Croton laevigatus. J. Nat. Prod. 2023, 86, 1345–1359. [Google Scholar] [CrossRef] [PubMed]
  9. Song, J.-Q.; Yang, K.-C.; Fan, X.-Z.; Deng, L.; Zhu, Y.-L.; Zhou, H.; Huang, Y.-S.; Kong, X.-Q.; Zhang, L.-J.; Liao, H.-B. Clerodane Diterpenoids with In-Vitro Anti-Neuroinflammatory Activity from the Tuberous Root of Tinospora sagittata (Menispermaceae). Phytochemistry 2024, 218, 113932. [Google Scholar] [CrossRef]
  10. Li, J.; Niu, L.; Huang, H.; Li, Q.; Xie, C.; Yang, C. Anti-Inflammatory Labdane Diterpenoids from the Aerial Parts of Leonurus sibiricus. Phytochemistry 2024, 217, 113927. [Google Scholar] [CrossRef]
  11. Tamuli, R.; Nguyen, T.; Macdonald, J.R.; Pierens, G.K.; Fisher, G.M.; Andrews, K.T.; Adewoyin, F.B.; Omisore, N.O.; Odaibo, A.B.; Feng, Y. Isolation and In Vitro and In Vivo Activity of Secondary Metabolites from Clerodendrum polycephalum Baker against Plasmodium Malaria Parasites. J. Nat. Prod. 2023, 86, 2661–2671. [Google Scholar] [CrossRef] [PubMed]
  12. Zhao, X.-T.; Lei, C.; You, J.-Q.; Zhao, T.; Yu, M.-H.; Shi, X.-L.; Hu, X.; Hou, A.-J. Dimeric Clerodane Diterpenoids and Antiviral Constituents of Dodonaea viscosa. Bioorg. Chem. 2021, 112, 104916. [Google Scholar] [CrossRef]
  13. Zhang, L.-T.; Wang, X.-L.; Wang, T.; Zhang, J.-S.; Huang, Z.-Q.; Shen, T.; Lou, H.-X.; Ren, D.-M.; Wang, X.-N. Dolabellane and Clerodane Diterpenoids from the Twigs and Leaves of Casearia kurzii. J. Nat. Prod. 2020, 83, 2817–2830. [Google Scholar] [CrossRef]
  14. Lei, C.; Wang, X.-H.; Liu, Y.-N.; Zhao, T.; Hu, Z.; Li, J.-Y.; Hou, A.-J. Clerodane Diterpenoids from Dodonaea viscosa and Their Inhibitory Effects on ATP Citrate Lyase. Phytochemistry 2021, 183, 112614. [Google Scholar] [CrossRef] [PubMed]
  15. Ren, X.; Yuan, X.; Jiao, S.-S.; He, X.-P.; Hu, H.; Kang, J.-J.; Luo, S.-H.; Liu, Y.; Guo, K.; Li, S.-H. Clerodane Diterpenoids from the Uygur Medicine Salvia deserta with Immunosuppressive Activity. Phytochemistry 2023, 214, 113823. [Google Scholar] [CrossRef] [PubMed]
  16. Li, C.; Sun, X.; Yin, W.; Zhan, Z.; Tang, Q.; Wang, W.; Zhuo, X.; Wu, Z.; Zhang, H.; Li, Y.; et al. Crassifolins Q−W: Clerodane Diterpenoids From Croton crassifolius With Anti-Inflammatory and Anti-Angiogenesis Activities. Front. Chem. 2021, 9, 733350. [Google Scholar] [CrossRef] [PubMed]
  17. Torres, F.R.; Pérez-Castorena, A.L.; Arredondo, L.; Toscano, R.A.; Nieto-Camacho, A.; Martínez, M.; Maldonado, E. Labdanes, Withanolides, and Other Constituents from Physalis nicandroides. J. Nat. Prod. 2019, 82, 2489–2500. [Google Scholar] [CrossRef]
  18. Wu, J.; Xiao, Q.; Xu, J.; Li, M.-Y.; Pan, J.-Y.; Yang, M. Natural Products from True Mangrove Flora: Source, Chemistry and Bioactivities. Nat. Prod. Rep. 2008, 25, 955. [Google Scholar] [CrossRef]
  19. Cadamuro, R.D.; Da Silveira Bastos, I.M.A.; Silva, I.T.; Da Cruz, A.C.C.; Robl, D.; Sandjo, L.P.; Alves, S.; Lorenzo, J.M.; Rodríguez-Lázaro, D.; Treichel, H.; et al. Bioactive Compounds from Mangrove Endophytic Fungus and Their Uses for Microorganism Control. J. Fungi 2021, 7, 455. [Google Scholar] [CrossRef]
  20. Cai, R.; Wu, Y.; Chen, S.; Cui, H.; Liu, Z.; Li, C.; She, Z. Peniisocoumarins A–J: Isocoumarins from Penicillium commune QQF-3, an Endophytic Fungus of the Mangrove Plant Kandelia candel. J. Nat. Prod. 2018, 81, 1376–1383. [Google Scholar] [CrossRef]
  21. Yu, G.; Sun, Z.; Peng, J.; Zhu, M.; Che, Q.; Zhang, G.; Zhu, T.; Gu, Q.; Li, D. Secondary Metabolites Produced by Combined Culture of Penicillium crustosum and a Xylaria sp. J. Nat. Prod. 2019, 82, 2013–2017. [Google Scholar] [CrossRef] [PubMed]
  22. Bai, M.; Zheng, C.-J.; Chen, G.-Y. Austins-Type Meroterpenoids from a Mangrove-Derived Penicillium sp. J. Nat. Prod. 2021, 84, 2104–2110. [Google Scholar] [CrossRef] [PubMed]
  23. Bai, M.; Zheng, C.-J.; Huang, G.-L.; Mei, R.-Q.; Wang, B.; Luo, Y.-P.; Zheng, C.; Niu, Z.-G.; Chen, G.-Y. Bioactive Meroterpenoids and Isocoumarins from the Mangrove-Derived Fungus Penicillium sp. TGM112. J. Nat. Prod. 2019, 82, 1155–1164. [Google Scholar] [CrossRef] [PubMed]
  24. Liu, S.; Dai, H.; Makhloufi, G.; Heering, C.; Janiak, C.; Hartmann, R.; Mándi, A.; Kurtán, T.; Müller, W.E.G.; Kassack, M.U.; et al. Cytotoxic 14-Membered Macrolides from a Mangrove-Derived Endophytic Fungus, Pestalotiopsis microspora. J. Nat. Prod. 2016, 79, 2332–2340. [Google Scholar] [CrossRef]
  25. Zheng, C.-J.; Huang, G.-L.; Liao, H.-X.; Mei, R.-Q.; Luo, Y.-P.; Chen, G.-Y.; Zhang, Q.-Y. Bioactive Cytosporone Derivatives Isolated from the Mangrove-Derived Fungus Dothiorella sp. ML002. Bioorg. Chem. 2019, 85, 382–385. [Google Scholar] [CrossRef]
  26. Li, W.-S.; Hu, H.-B.; Huang, Z.-H.; Yan, R.-J.; Tian, L.-W.; Wu, J. Phomopsols A and B from the Mangrove Endophytic Fungus Phomopsis sp. Xy21: Structures, Neuroprotective Effects, and Biogenetic Relationships. Org. Lett. 2019, 21, 7919–7922. [Google Scholar] [CrossRef] [PubMed]
  27. Meng, L.-H.; Wang, C.-Y.; Mándi, A.; Li, X.-M.; Hu, X.-Y.; Kassack, M.U.; Kurtán, T.; Wang, B.-G. Three Diketopiperazine Alkaloids with Spirocyclic Skeletons and One Bisthiodiketopiperazine Derivative from the Mangrove-Derived Endophytic Fungus Penicillium brocae MA-231. Org. Lett. 2016, 18, 5304–5307. [Google Scholar] [CrossRef]
  28. Li, H.-L.; Xu, R.; Li, X.-M.; Yang, S.-Q.; Meng, L.-H.; Wang, B.-G. Simpterpenoid A, a Meroterpenoid with a Highly Functionalized Cyclohexadiene Moiety Featuring Gem -Propane-1,2-Dione and Methylformate Groups, from the Mangrove-Derived Penicillium simplicissimum MA-332. Org. Lett. 2018, 20, 1465–1468. [Google Scholar] [CrossRef]
  29. Chen, S.; Cai, R.; Liu, Z.; Cui, H.; She, Z. Secondary metabolites from mangrove-associated fungi: Source, chemistry and bioac-tivities. Nat. Prod. Rep. 2022, 3, 560–595. [Google Scholar] [CrossRef]
  30. Wang, G.; Yuan, Y.; Li, Z.; Liu, X.; Chu, Y.; She, Z.; Kang, W.; Chen, Y. Pleosmaranes A–R, Isopimarane and 20-nor Isopimarane Diterpenoids with Anti-Inflammatory Activities from the Mangrove Endophytic Fungus Pleosporales sp. HNQQJ-1. J. Nat. Prod. 2024, 87, 304–314. [Google Scholar] [CrossRef]
  31. Chen, Y.; Yang, W.; Zhu, G.; Wang, G.; Chen, T.; Li, H.; Yuan, J.; She, Z. Didymorenloids A and B, Two Polycyclic Cyclopenta[b]Fluorene-Type Alkaloids with Anti-Hepatoma Activity from the Mangrove Endophytic Fungus Didymella sp. CYSK-4. Org. Chem. Front. 2024, 11, 1706–1712. [Google Scholar] [CrossRef]
  32. Liu, Y.; Chen, T.; Sun, B.; Tan, Q.; Ouyang, H.; Wang, B.; Yu, H.; She, Z. Mono- and Dimeric Sorbicillinoid Inhibitors Targeting IL-6 and IL-1β from the Mangrove-Derived Fungus Trichoderma Reesei BGRg-3. Int. J. Mol. Sci. 2023, 24, 16096. [Google Scholar] [CrossRef] [PubMed]
  33. Jia, H.; Wu, L.; Liu, R.; Li, J.; Liu, L.; Chen, C.; Li, J.; Zhang, K.; Liao, J.; Long, Y. Penifuranone A: A Novel Alkaloid from the Mangrove Endophytic Fungus Penicillium Crustosum SCNU-F0006. Int. J. Mol. Sci. 2024, 25, 5032. [Google Scholar] [CrossRef] [PubMed]
  34. Cui, H.; Liu, Y.; Li, J.; Huang, X.; Yan, T.; Cao, W.; Liu, H.; Long, Y.; She, Z. Diaporindenes A–D: Four Unusual 2,3-Dihydro-1 H -Indene Analogues with Anti-Inflammatory Activities from the Mangrove Endophytic Fungus Diaporthe sp. SYSU-HQ3. J. Org. Chem. 2018, 83, 11804–11813. [Google Scholar] [CrossRef] [PubMed]
  35. Chen, Y.; Yang, W.; Zou, G.; Wang, G.; Kang, W.; Yuan, J.; She, Z. Cytotoxic Bromine- and Iodine-Containing Cytochalasins Produced by the Mangrove Endophytic Fungus Phomopsis sp. QYM-13 Using the OSMAC Approach. J. Nat. Prod. 2022, 85, 1229–1238. [Google Scholar] [CrossRef] [PubMed]
  36. Minhas, R.; Bansal, Y.; Bansal, G. Inducible Nitric Oxide Synthase Inhibitors: A Comprehensive Update. Med. Res. Rev. 2020, 40, 823–855. [Google Scholar] [CrossRef] [PubMed]
  37. Miller, A.H.; Raison, C.L. The Role of Inflammation in Depression: From Evolutionary Imperative to Modern Treatment Target. Nat. Rev. Immunol. 2016, 16, 22–34. [Google Scholar] [CrossRef]
  38. Zhu, J.; Song, W.; Li, L.; Fan, X. Endothelial Nitric Oxide Synthase: A Potential Therapeutic Target for Cerebrovascular Diseases. Mol. Brain 2016, 9, 30. [Google Scholar] [CrossRef] [PubMed]
  39. Wang, X.; Ren, Z.; He, Y.; Xiang, Y.; Zhang, Y.; Qiao, Y. A Combination of Pharmacophore Modeling, Molecular Docking and Virtual Screening for iNOS Inhibitors from Chinese Herbs. Bio-Med. Mater. Eng. 2014, 24, 1315–1322. [Google Scholar] [CrossRef]
  40. You, J.; Liu, Y.; Zhou, J.; Sun, X.; Lei, C.; Mu, Q.; Li, J.; Hou, A. cis-Clerodane Diterpenoids with Structural Diversity and Anti-inflammatory Activity from Tinospora crispa. Chin. J. Chem. 2022, 40, 2882–2892. [Google Scholar] [CrossRef]
  41. Zhu, Y.-L.; Deng, L.; Dai, X.-Y.; Song, J.-Q.; Zhu, Y.; Liu, T.; Kong, X.-Q.; Zhang, L.-J.; Liao, H.-B. Tinopanoids K-T, Clerodane Diterpenoids with Anti-Inflammatory Activity from Tinospora crispa. Bioorg. Chem. 2023, 140, 106812. [Google Scholar] [CrossRef] [PubMed]
  42. Zhu, Y.-L.; Deng, L.; Song, J.-Q.; Zhu, Y.; Yuan, R.-W.; Fan, X.-Z.; Zhou, H.; Huang, Y.-S.; Zhang, L.-J.; Liao, H.-B. Clerodane Diterpenoids with Anti-Inflammatory and Synergistic Antibacterial Activities from Tinospora crispa. Org. Chem. Front. 2022, 9, 6945–6957. [Google Scholar] [CrossRef]
Figure 1. Structure of compounds 15.
Figure 1. Structure of compounds 15.
Ijms 25 06691 g001
Figure 2. Key HMBC and COSY correlations of 15.
Figure 2. Key HMBC and COSY correlations of 15.
Ijms 25 06691 g002
Figure 3. Key NOESY correlations of compounds 15.
Figure 3. Key NOESY correlations of compounds 15.
Ijms 25 06691 g003
Figure 4. Experimental and calculated ECD spectra of compounds 15 in MeOH.
Figure 4. Experimental and calculated ECD spectra of compounds 15 in MeOH.
Ijms 25 06691 g004
Figure 5. (A) Comparisons of calculated and experimental 13C NMR data of 4 (5S, 10S, 14S) in CDCl3; (B) DP4+ analysis of compound 4 including isomer 1 (5S, 10S, 14S) and isomer 2 (5S, 10S, 14R) in CDCl3.
Figure 5. (A) Comparisons of calculated and experimental 13C NMR data of 4 (5S, 10S, 14S) in CDCl3; (B) DP4+ analysis of compound 4 including isomer 1 (5S, 10S, 14S) and isomer 2 (5S, 10S, 14R) in CDCl3.
Ijms 25 06691 g005
Figure 6. Single-crystal X-ray structures of compound 5.
Figure 6. Single-crystal X-ray structures of compound 5.
Ijms 25 06691 g006
Table 1. 1H NMR (600 MHz) data of compounds 15 (δH in ppm, J in Hz).
Table 1. 1H NMR (600 MHz) data of compounds 15 (δH in ppm, J in Hz).
No.1 b2 a3 b4 a5 a
1a1.67, m1.68, m1.73, m1.68, m2.05, m
1b1.20, overlap1.22, overlap1.26, m1.19, m
2a1.65, m1.45, m1.64, m1.69, m1.91, m
2b1.39, overlap1.21, overlap1.48, overlap1.21, m
3a1.38, m1.39, m1.43, m1.38, m4.70, dd (3.5, 2.2)
3b1.15, m1.16, m1.19, m1.15, m
51.18, m1.22, overlap1.27, overlap1.20, overlap
6a1.57, m1.58, m1.74, overlap1.58, m
6b1.47, m1.27, m1.27, overlap1.45, m
71.99, m2.04, m2.05, m2.08, m4.74, s
11a3.23, d (17.4)3.10, d (17.3)3.03, d (16.7)3.20, d (17.4)1.76, m
11b3.04, d (17.4)2.99, d (17.3)2.90, d (16.7)3.00, d (17.4)1.69, m
12a 1.96, m
12b 1.49, m
13a2.84, d (14.6)2.78, d (16.0)5.65, s1.88, d (7.5)
13b2.71, d (14.6)2.54 d (16.0)
14 1.82, m5.88, s
15a5.49, m5.32, t (7.1)2.23, t (7.1)1.59, m5.82, dd (17.5, 10.6)
15b 1.36, m
16a4.18, m4.15, d (7.1)3.62, t (7.1)3.68, m5.04, dd (17.5, 1.0)
16b 4.99, dd (10.6, 1.0)
171.62, s1.62, s1.56, s0.84, overlap1.00, s
180.83, s0.84, s0.87, s0.83, s1.27, s
190.89, s0.89, s0.91, s0.89, s1.30, s
200.95, s0.98, s1.02, s0.95, s
22 2.13, s
a Measured in CDCl3, b Measured in MeOH-d4.
Table 2. 13C NMR (150 MHz) data of compounds 15 (δC in ppm).
Table 2. 13C NMR (150 MHz) data of compounds 15 (δC in ppm).
No.1 b2 a3 b4 a5 a
136.3, CH236.2, CH2,37.4, CH236.4, CH2,14.4, CH2
218.9, CH218.9, CH219.9, CH219.1, CH221.8, CH2
341.6, CH241.6, CH242.9, CH241.6, CH280.2, CH
433.4, C33.5, C34.2, C33.5, C40.8, C
551.4, CH51.4, CH52.7, CH51.4, CH83.3, C
619.0, CH219.0 c, CH220.0, CH219.0, CH2105.0, C
731.1, CH231.9, CH232.6, CH231.1, CH270.9, CH
8132.1, C132.0, C134.1, C133.6, C135.4, C
9135.8, C136.7, C137.6, C135.2, C73.2, C
1039.1, C39.1, C39.7, C39.1, C55.9, C
1132.7, CH232.7, CH234.7, CH232.8, CH227.2, CH2
12178.0, C177.0, C176.9, C171.2, C29.6, CH2
1335.9, CH243.3, CH2129.2, CH41.2, CH238.3, C
14138.3, C137.8, C135.1, C28.4, CH135.9, CH
15125.6, CH123.2, CH43.0, CH240.1, CH2146.9, CH
1659.1, CH259.5, CH261.8, CH261.2, CH2111.7, CH2
1722.9, CH316.8, CH317.2, CH319.4, CH324.3, CH3
1821.8, CH321.8, CH322.1, CH321.8, CH324.4, CH3
1933.3, CH333.3, CH333.7, CH333.3, CH322.2, CH3
2019.9, CH320.2, CH320.4, CH320.2, CH3172.7, C
21 168.9, C
22 21.4, CH3
a Measured in CDCl3, b Measured in MeOH-d4, c overlap in 13C NMR.
Table 3. Inhibitory Effects against NO Production of Compounds 15 in LPS-Induced RAW264.7 Cells.
Table 3. Inhibitory Effects against NO Production of Compounds 15 in LPS-Induced RAW264.7 Cells.
Compounds12345Quercetin
IC50 (μM)15.784.59>5021.6013.3811.33
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Wang, G.; Wu, J.; Li, Z.; Chen, T.; Liu, Y.; Wang, B.; Chen, Y.; She, Z. Talaroacids A–D and Talaromarane A, Diterpenoids with Anti-Inflammatory Activities from Mangrove Endophytic Fungus Talaromyces sp. JNQQJ-4. Int. J. Mol. Sci. 2024, 25, 6691. https://doi.org/10.3390/ijms25126691

AMA Style

Wang G, Wu J, Li Z, Chen T, Liu Y, Wang B, Chen Y, She Z. Talaroacids A–D and Talaromarane A, Diterpenoids with Anti-Inflammatory Activities from Mangrove Endophytic Fungus Talaromyces sp. JNQQJ-4. International Journal of Molecular Sciences. 2024; 25(12):6691. https://doi.org/10.3390/ijms25126691

Chicago/Turabian Style

Wang, Guisheng, Jianying Wu, Zhaokun Li, Tao Chen, Yufeng Liu, Bo Wang, Yan Chen, and Zhigang She. 2024. "Talaroacids A–D and Talaromarane A, Diterpenoids with Anti-Inflammatory Activities from Mangrove Endophytic Fungus Talaromyces sp. JNQQJ-4" International Journal of Molecular Sciences 25, no. 12: 6691. https://doi.org/10.3390/ijms25126691

APA Style

Wang, G., Wu, J., Li, Z., Chen, T., Liu, Y., Wang, B., Chen, Y., & She, Z. (2024). Talaroacids A–D and Talaromarane A, Diterpenoids with Anti-Inflammatory Activities from Mangrove Endophytic Fungus Talaromyces sp. JNQQJ-4. International Journal of Molecular Sciences, 25(12), 6691. https://doi.org/10.3390/ijms25126691

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop